Tal Zvi Zaks Moderna, Inc. (MRNA) insider trading activity

Tal Zvi Zaks is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 0 shares of MRNA, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2021, when has been sold 5,000 shares (Common Stock) at a price of $237.0 per share, resulting in proceeds of $1,185,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Tal Zvi Zaks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2021	SELL Open market or private sale	$1,185,000 $237.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 30 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jun 23 2021	SELL Open market or private sale	$1,098,250 $219.65 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 23 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jun 16 2021	SELL Open market or private sale	$1,000,000 $200.0 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jun 09 2021	SELL Open market or private sale	$1,061,500 $212.3 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 09 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
Jun 02 2021	SELL Open market or private sale	$919,500 $183.9 p/Share	5,000 Reduced 100.0%	0 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
May 26 2021	SELL Open market or private sale	$843,500 $168.7 p/Share	5,000 Reduced 100.0%	0 Common Stock
May 26 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
May 19 2021	SELL Open market or private sale	$778,700 $155.74 p/Share	5,000 Reduced 100.0%	0 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
May 12 2021	SELL Open market or private sale	$770,550 $154.11 p/Share	5,000 Reduced 100.0%	0 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$129,650 $25.93 p/Share	5,000 Added 50.0%	5,000 Common Stock
May 10 2021	SELL Open market or private sale	$585,585 $159.56 p/Share	3,670 Reduced 100.0%	0 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$44,811 $12.21 p/Share	3,670 Added 50.0%	3,670 Common Stock
May 03 2021	SELL Open market or private sale	$929,350 $185.87 p/Share	5,000 Reduced 100.0%	0 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 26 2021	SELL Open market or private sale	$873,250 $174.65 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 26 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 19 2021	SELL Open market or private sale	$819,700 $163.94 p/Share	5,000 Reduced 100.0%	0 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$61,050 $12.21 p/Share	5,000 Added 50.0%	5,000 Common Stock
Apr 12 2021	SELL Open market or private sale	$699,750 $139.95 p/Share	5,000 Reduced 100.0%	0 Common Stock

Also insider at

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare

TZZ

Tal Zvi Zaks

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account